Pharmacogenetics: the Dx perspective

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Expert Review of Molecular Diagnostics

• Publication date

  2001-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/14737159.1.4.371PMID 11901851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Immunodeficiency Virus Type 1 Drug Resistance Testing: a Comparison of Three Sequence-Based Methods

  2001cited by this paper
• Pharmacogenetics: theRx perspective

  2001cited by this paper
• Pyrosequencing Sheds Light on DNA Sequencing

  2001cited by this paper
• Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care.

  2001cited by this paper
• Combining nucleic acid amplification and detection.

  2001cited by this paper
• Miniaturization technologies for molecular diagnostics.

  2001cited by this paper
• Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies.

  2001cited by this paper
• Electronic detection of nucleic acids: a versatile platform for molecular diagnostics.

  2001cited by this paper
• Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes.

  2000cited by this paper
• Large-scale SNP scoring from unamplified genomic DNA.

  2000cited by this paper
• Pharmacology and therapeutic use of trastuzumab in breast cancer.

  2000cited by this paper
• Mutation Detection in K‐ras, BRCA1, BRCA2, and p53 Using PCR/LDR and a Universal DNA Microarray

  2000cited by this paper
• The use of HER2 testing in the management of breast cancer.

  2000cited by this paper
• A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

  2000cited by this paper
• Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?

  2000cited by this paper
• Comparative Evaluation of Three Human Immunodeficiency Virus Genotyping Systems: the HIV-GenotypR Method, the HIV PRT GeneChip Assay, and the HIV-1 RT Line Probe Assay

  2000cited by this paper
• Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

  2000cited by this paper
• Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays.

  2000cited by this paper
• Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

  2000cited by this paper
• Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry.

  2000cited by this paper
• Recent developments in DNA sequencing by capillary and microdevice electrophoresis

  1999cited by this paper
• Impact of pharmacogenomics on the clinical laboratory.

  1999cited by this paper
• Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

  1999cited by this paper
• Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

  1999cited by this paper
• Mutational analysis using oligonucleotide microarrays

  1999cited by this paper
• c‐erbB‐2 (HER‐2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy

  1999cited by this paper
• Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

  1999cited by this paper
• Multiplex detection of single-nucleotide variations using molecular beacons.

  1999cited by this paper
• Simultaneous Polymerase Chain Reaction Restriction Fragment Length Polymorphism Identification of the Factor V Leiden Allele and the Prothrombin 20210A Mutation

  1998cited by this paper
• New goals for the U.S. Human Genome Project: 1998-2003.

  1998cited by this paper
• Genotyping by mass spectrometric analysis of short DNA fragments

  1998cited by this paper
• Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome.

  1998cited by this paper
• Detection and quantification of the A3243G mutation of mitochondrial DNA by ligation detection reaction.

  1998cited by this paper
• DNA chips: State-of-the art

  1998cited by this paper
• Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry.

  1997cited by this paper
• Detection of heterozygous mutations in brca1 using high density oligonucleotide arrays and two-color fluorescence analysis

  1997cited by this paper
• The role of nucleic acid amplification and detection in the clinical microbiology laboratory.

  1996cited by this paper
• Probabilities of sexual HIV‐1 transmission

  1996cited by this paper
• Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis

  1996cited by this paper
• The role of nucleic acid amplification and detection in the clinical microbiology laboratory.

  1996cited by this paper
• Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays

  1996cited by this paper
• HIV viral dynamics.

  1996cited by this paper
• Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine

  1995cited by this paper
• Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.

  1995cited by this paper
• Nucleic acid amplification technologies.

  1993cited by this paper
• Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.

  1993cited by this paper
• The long term prognostic significance of c-erbB-2 in primary breast cancer.

  1991cited by this paper

• Pharmacogenomic Applications in Children

  2008cites this paper
• Recent development in pharmacogenomics: from candidate genes to genome-wide association studies

  2007cites this paper
• Promises of Biomarkers in Drug Development – A Reality Check

  2007cites this paper
• Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.

  2005cites this paper
• Future potential of thymidylate synthase inhibitors in cancer therapy

  2002cites this paper
• Cytochrome P450 Genotyping by Multiplexed Real-Time DNA Sequencing with Pyrosequencing™ Technology

  2002cites this paper